Concord Health Partners is a healthcare-focused investment firm that partners with management teams to build leading healthcare companies. The firm invests in companies with innovative technologies and solutions that advance healthcare through operational efficiencies, improved patient outcomes, and expanded access to care.
44% of their portfolio is in Healthcare. Average disclosed round size is $57.2M (across 14 rounds with reported amounts).
Portfolio
11
Fund Size
$150M
Top Stage
Unknown
Last 12 Mo
3
Team
Doug Shaw
Operating Partner
Harsh Trivedi, MD
Operating Partner
Joseph Swedish
Partner Emeritus
Nathan Goldstein
Operating Partner
Nick Patel, MD
Operating Partner
Brian Belsky
Consultant
Bruce Lawrence
Senior Advisor
Chris DeRienzo, MD, MPP
AHA Special Advisor
Scott Nordlund
Concord Advisor
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Thyme | Series E | $125M | Sep 2026 |
 Thyme Care | Series D | $97M | Sep 2025 |
| Thyme | Series D | $97M | Sep 2025 |
 Pieces | Growth | $25M | Sep 2024 |
| Thyme Care | Series C | $95M | Jul 2024 |
 NeuroFlow | Unknown | — | Sep 2023 |
 Iris Telehealth | Series B | $40M | Apr 2022 |
 Cedar | Series D | $200M | Mar 2021 |
 Cylera | Series A | $10M | Jan 2021 |
| MMIVI | Series B | $35M | Jan 2021 |
 Bright.md | Series C | $16.7M | May 2020 |
| MMIVI | Unknown | $45M | Jan 2020 |
| VVitalTech | Series A | — | Sep 2019 |
| MMIVI | Unknown | $3.2M | Jan 2019 |
| MMIVI | Unknown | $1.6M | Jan 2017 |
 MedNition | Series A | $10M | — |
Top Co-Investors
Last updated: 8 September 2026